Artioli Elena, Mazzotti Antonio, Ramacci Vanina, Zielli Simone Ottavio, Digennaro Vitantonio, Ruffilli Alberto, Faldini Cesare
IRCCS Istituto Ortopedico Rizzoli, 1st Orthopaedics and Traumatology clinic - University of Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 1st Orthopaedics and Traumatology clinic - University of Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, 40123 Bologna, Italy.
Knee. 2023 Jan;40:52-62. doi: 10.1016/j.knee.2022.11.009. Epub 2022 Nov 18.
Temporary isolated medial femoral hemiepiphysiodesis (TIMFH) represents a safe and effective technique widely used to treat idiopathic genu valgum. Recent studies mainly concentrated on comparing outcomes of different implants, while less attention has been reserved to the proper indications and timing for surgery. The aim of this systematic review was to provide evidence-based guidelines about indications for device implant and removal and postoperative management.
A comprehensive literature search was performed across three databases to select articles concerning TIMFH in the treatment of idiopathic genu valgum. Studies involving other etiologies or concomitant surgical procedures were excluded. Quality assessment of the included studies was conducted through the Newcastle-Ottawa Scale.
Ten studies involving 237 patients for a total of 446 knees were included in the analysis. Mean age at surgery was 11,4 years. Patients were considered for surgery using various clinical and radiological parameters. Intermalleolar distance (IMD) and mechanical lateral distal femoral angle (mLDFA) were the most common evaluated. Mean treatment time was 12 months. Rebound of the deformity occurred in 6,7% of cases.
Results of this review showed good consensus among authors. Patients undergoing TIMFH for IGV should be minimum 8 years old, with an IMD greater than 8 cm and a mLDFA lower than 87°. Postoperative management should comprise of quarterly clinic evaluations, and follow-up should last until skeletal maturity. The application of more uniform parameters in clinical practice may improve the establishment of the optimal timing for implant removal.
临时孤立性股骨内侧半骨骺阻滞术(TIMFH)是一种广泛用于治疗特发性膝外翻的安全有效技术。近期研究主要集中于比较不同植入物的疗效,而对手术的合适适应证和时机关注较少。本系统评价的目的是提供关于器械植入、取出及术后管理适应证的循证指南。
在三个数据库中进行全面的文献检索,以筛选关于TIMFH治疗特发性膝外翻的文章。排除涉及其他病因或同期手术的研究。通过纽卡斯尔-渥太华量表对纳入研究进行质量评估。
分析纳入了10项研究,共237例患者、446个膝关节。手术时的平均年龄为11.4岁。使用多种临床和影像学参数来决定患者是否适合手术。最常评估的是踝间距(IMD)和机械性股骨外侧远端角(mLDFA)。平均治疗时间为12个月。6.7%的病例出现畸形复发。
本综述结果显示作者之间有良好的共识。接受TIMFH治疗IGV的患者年龄应至少8岁,IMD大于8cm且mLDFA低于87°。术后管理应包括每季度的门诊评估,随访应持续至骨骼成熟。在临床实践中应用更统一的参数可能会改善植入物取出最佳时机的确定。